The legislature's own summary of the bill, or its official long title.
Amends the Cancer Clinical Trial Participation Program Act. Changes the short title of the Act to the Clinical Trial Participation Program Act. Throughout the Act, replaces references to "cancer clinical trial" with references to "clinical trial" and makes conforming changes. Provides that "clinical trial" includes a voluntary research study conducted on people and designed to answer specific questions about the…
Read the full title (93 words)
Amends the Cancer Clinical Trial Participation Program Act. Changes the short title of the Act to the Clinical Trial Participation Program Act. Throughout the Act, replaces references to "cancer clinical trial" with references to "clinical trial" and makes conforming changes. Provides that "clinical trial" includes a voluntary research study conducted on people and designed to answer specific questions about the safety or effectiveness of a drug, vaccine, therapy, medical device, medical diagnostic, or new way of using an existing treatment to treat or diagnose a condition. Defines "condition". Makes other changes. Effective immediately.
Every action
37 steps, oldest first, as the legislature records them.
Show the 29 earlier steps
SenateFiled with Secretary by Sen. Adriane Johnson
SenateFirst Reading
CommitteeReferred to Assignments · Senate Assignments
SenateAdded as Co-Sponsor Sen. Laura M. Murphy
CommitteeAssigned to Public Health · Senate Public Health
SenateAdded as Co-Sponsor Sen. Linda Holmes
SenateAdded as Co-Sponsor Sen. Paul Faraci
SenateAdded as Co-Sponsor Sen. Cristina Castro
CommitteeDo Pass Public Health; 007-000-000 · Senate Public Health
SenatePlaced on Calendar Order of 2nd Reading March 9, 2023
SenateAdded as Co-Sponsor Sen. Willie Preston
SenateSecond Reading
SenatePlaced on Calendar Order of 3rd Reading March 21, 2023
SenateAdded as Co-Sponsor Sen. Mary Edly-Allen
SenatePlaced on Calendar Order of 3rd Reading ** March 24, 2023
SenateAdded as Co-Sponsor Sen. Sara Feigenholtz
SenateThird Reading - Passed; 057-000-000
HouseArrived in House
HouseChief House Sponsor Rep. Camille Y. Lilly
HouseFirst Reading
CommitteeReferred to Rules Committee · House Rules
CommitteeAssigned to Appropriations-Health & Human Services Committee · House Approp-Health & Human Services
HouseCommittee/Final Action Deadline Extended-9(b) May 19, 2023
HouseAdded Alternate Chief Co-Sponsor Rep. Edgar Gonzalez, Jr.
CommitteeMotion Filed to Suspend Rule 21 Human Services Committee; Rep. Robyn Gabel · House Human Services
HouseMotion to Suspend Rule 21 - Prevailed 071-040-000
HouseAdded Alternate Co-Sponsor Rep. Margaret Croke
CommitteeDo Pass / Short Debate Appropriations-Health & Human Services Committee; 023-000-000 · House Approp-Health & Human Services
HousePlaced on Calendar 2nd Reading - Short Debate
HouseSecond Reading - Short Debate
HousePlaced on Calendar Order of 3rd Reading - Short Debate
HouseThird Reading - Short Debate - Passed 111-000-000
SenatePassed Both Houses
SenateSent to the Governor
SenateGovernor Approved
SenateEffective Date June 30, 2023
SenatePublic Act . . . . . . . . . 103-0227
Roll calls
4 recorded votes: 2 on the floor, 2 in committee. Each shows how every member voted.
